| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.37 | 5e-13 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-09 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 3e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 9e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 2e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |